These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31489226)

  • 1. The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn.
    Newberry C; Lynch K
    J Thorac Dis; 2019 Aug; 11(Suppl 12):S1594-S1601. PubMed ID: 31489226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Food in Relation to Gastroesophageal Reflux Disease (GERD).
    Herdiana Y
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.
    Richter JE
    Gastroenterol Hepatol (N Y); 2014 Sep; 10(9):547-55. PubMed ID: 27551249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Yadlapati R; DeLay K
    Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medical Management of Gastroesophageal Reflux Disease: A Narrative Review.
    Kröner PT; Cortés P; Lukens FJ
    J Prim Care Community Health; 2021; 12():21501327211046736. PubMed ID: 34581222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
    Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
    J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
    Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
    Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Management of Gastroesophageal Reflux Disease: Revisited.
    Nabi Z; Reddy DN
    Clin Endosc; 2016 Sep; 49(5):408-416. PubMed ID: 27744659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy.
    Borbély Y; Bouvy N; Schulz HG; Rodriguez LA; Ortiz C; Nieponice A
    Surg Obes Relat Dis; 2018 May; 14(5):611-615. PubMed ID: 29567054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for the treatment of gastroesophageal reflux disease].
    Lee JH; Cho YK; Jeon SW; Kim JH; Kim NY; Lee JS; Bak YT;
    Korean J Gastroenterol; 2011 Feb; 57(2):57-66. PubMed ID: 21350318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease.
    Morozov S; Isakov V; Konovalova M
    World J Gastroenterol; 2018 Jun; 24(21):2291-2299. PubMed ID: 29881238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.